Yourgene Health (YGEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.28p
   
  • Change Today:
    -0.010p
  • 52 Week High: 10.00p
  • 52 Week Low: 0.28p
  • Currency: UK Pounds
  • Shares Issued: 3,176.96m
  • Volume: 7,150,502
  • Market Cap: 8.90m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Sep-22 Interim 9.56 (6.23) (0.80)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 6.15 (9.54) (3.00)p n/a n/a n/a n/a 0.0%
31-Mar-19 8.88 3.39 0.90p 13.9 n/a n/a n/a 0.0%
31-Mar-20 16.61 (3.38) (0.40)p n/a n/a n/a n/a 0.0%
31-Mar-21 18.29 (12.00) (1.80)p n/a n/a n/a n/a 0.0%
31-Mar-22 37.56 (3.19) (0.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 18.25 (8.90) (0.62)p n/a n/a n/a n/a 0.0%
31-Mar-24 19.65 (5.60) (0.18)p n/a n/a n/a n/a 0.0%
31-Mar-25 22.55 (3.70) (0.11)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 13.89 n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

YGEN Market Data

Currency UK Pounds
Share Price 0.28p
Change Today -0.010p
% Change -3.36 %
52 Week High 10.00p
52 Week Low 0.28p
Volume 7,150,502
Shares Issued 3,176.96m
Market Cap 8.90m

YGEN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.04% above the market average68.04% above the market average68.04% above the market average68.04% above the market average68.04% above the market average
76.27% above the sector average76.27% above the sector average76.27% above the sector average76.27% above the sector average76.27% above the sector average
Price Trend
99.78% below the market average99.78% below the market average99.78% below the market average99.78% below the market average99.78% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
56.59% above the market average56.59% above the market average56.59% above the market average56.59% above the market average56.59% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

YGEN Dividends

No dividends found

Trades for 29-Mar-2023

Time Volume / Share Price
15:45 164,932 @ 0.29p
12:30 1,000,000 @ 0.28p
12:27 1,000,000 @ 0.28p
12:01 1,300,000 @ 0.29p
11:58 3,500,000 @ 0.28p

YGEN Key Personnel

CEO Lyn Rees

Top of Page